Sarcopenic obesity, defined by the coexistence of increased fat mass and decreased muscle mass and function, is a major challenge, particularly in the elderly. This condition is associated with increased morbidity and mortality. Early identification of affected patients is critical to implement age-appropriate and comorbidity-adapted management strategies. This article reviews the pathophysiological mechanisms, diagnostic methods, and recent therapeutic approaches.